|
1
|
Wall ME and Wani MC: Camptothecin and
taxol: From discovery to clinic. J Ethnopharmacol. 51:239–254.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Giovanella BC, Hinz HR, Kozielski AJ,
Stehlin JS Jr, Silber R and Potmesil M: Complete growth inhibition
of human cancer xenografts in nude mice by treatment with
20-(S)-camptothecin. Cancer Res. 51:3052–3055.
1991.PubMed/NCBI
|
|
3
|
Martino E, Della Volpe S, Terribile E,
Benetti E, Sakaj M, Centamore A, Sala A and Collina S: The long
story of camptothecin: from traditional medicine to drugs. Bioorg
Med Chem Lett. 27:701–707. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ryan JJ: Tyrosine kinase inhibitors in
pulmonary vascular disease. JACC Basic Transl Sci. 1:684–686. 2016.
View Article : Google Scholar
|
|
5
|
Rahman Jazieh A, Abdelhafiez N, Al Olayan
A, Bamefleh H and Loutfi S: Tyrosine kinase inhibitors: What after
complete remission of lung cancer? Cancer Treat Res Commun.
11:17–20. 2017. View Article : Google Scholar
|
|
6
|
Cayssials E and Guilhot F: Beyond tyrosine
kinase inhibitors: Combinations and other agents. Best Pract Res
Clin Haematol. 29:271–283. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lin Z, Zhang Q and Luo W: Angiogenesis
inhibitors as therapeutic agents in cancer: Challenges and future
directions. Eur J Pharmacol. 793:76–81. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang Z, Dabrosin C, Yin X, Fuster MM,
Arreola A, Rathmell WK, Generali D, Nagaraju GP, El-Rayes B,
Ribatti D, et al: Broad targeting of angiogenesis for cancer
prevention and therapy. Semin Cancer Biol. 35 Suppl:S224–S243.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kise K, Kinugasa-Katayama Y and Takakura
N: Tumor microenvironment for cancer stem cells. Adv Drug Deliv
Rev. 99:197–205. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Umesalma S, Nagendraprabhu P and
Sudhandiran G: Ellagic acid inhibits proliferation and induced
apoptosis via the Akt signaling pathway in HCT-15 colon
adenocarcinoma cells. Mol Cell Biochem. 399:303–313. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tyagi A, Singh RP, Agarwal C and Agarwal
R: Silibinin activates p53-caspase 2 pathway and causes
caspase-mediated cleavage of Cip1/p21 in apoptosis induction in
bladder transitional-cell papilloma RT4 cells: Evidence for a
regulatory loop between p53 and caspase 2. Carcinogenesis.
27:2269–2280. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chargari C, Leteur C, Angevin E, Bashir T,
Schoentjes B, Arts J, Janicot M, Bourhis J and Deutsch E:
Preclinical assessment of JNJ-26854165 (Serdemetan1), a novel
tryptamine compound with radiosensitizing activity in vitro
and in tumor xenografts. Cancer Lett. 312:209–218. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang H and Yan C: A small-molecule p53
activator induces apoptosis through inhibiting MDMX expression in
breast cancer cells. Neoplasia. 13:611–619. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hasanzadeh M, Shadjou N and de la Guardia
M: Current advancement in immunosensing of p53 tumor suppressor
protein based on nanomaterials: Analytical approach. TrAC Trends in
Analyt Chem. 89:13–20. 2017. View Article : Google Scholar
|
|
15
|
Enoch T and Norbury C: Cellular responses
to DNA damage: Cell-cycle checkpoints, apoptosis and the roles of
p53 and ATM. Trends Biochem Sci. 20:426–430. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lazo PA: Reverting p53 activation after
recovery of cellular stress to resume with cell cycle progression.
Cell Signal. 33:49–58. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zeng L, Li T, Xu DC, Liu J, Mao G, Cui MZ,
Fu X and Xu X: Death receptor 6 induces apoptosis not through type
I or type II pathways, but via a unique mitochondria-dependent
pathway by interacting with Bax protein. J Biol Chem.
287:29125–29133. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ha M, Wei L, Guan X, Li L and Liu C:
p53-dependent apoptosis contributes to di-(2-ethylhexyl)
phthalate-induced hepatotoxicity. Environ Pollut. 208:416–425.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gao CF, Ren S, Zhang L, Nakajima T,
Ichinose S, Hara T, Koike K and Tsuchida N: Caspase-dependent
cytosolic release of cytochrome c and membrane translocation
of bax in p53-induced apoptosis. Exp Cell Res. 265:145–151. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Feng JH: Establishment of a cell strain
from human kidney cell carcinoma KCC-853. Zhonghua Bing Li Xue Za
Zhi. 17:102–104. 1988.(In Chinese). PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lopez J and Tait SW: Mitochondrial
apoptosis: killing cancer using the enemy within. Br J Cancer.
112:957–962. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yuan H, Cao Y, Li L, Wang S, Yang D, Zhong
X, Tang S and Yuan S: SM-1 induces apoptosis of BGC-823 cells by
activating procaspase-3 and exerts antitumor effect. Mil Med Sci.
40:326–330. 2016.
|
|
24
|
Barre B and Perkins ND: A cell cycle
regulatory network controlling NF-kappaB subunit activity and
function. EMBO J. 26:4841–4855. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fu Y, Kadioglu O, Wiench B, Wei Z, Gao C,
Luo M, Gu C, Zu Y and Efferth T: Cell cycle arrest and induction of
apoptosis by cajanin stilbene acid from Cajanus cajan in
breast cancer cells. Phytomedicine. 22:462–468. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li Y, Yang F, Zheng W, Hu M, Wang J, Ma S,
Deng Y, Luo Y, Ye T and Yin W: Punica granatum (pomegranate)
leaves extract induces apoptosis through mitochondrial intrinsic
pathway and inhibits migration and invasion in non-small cell lung
cancer in vitro. Biomed Pharmacother. 80:227–235. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pasetto LM, D'Andrea MR, Brandes AA, Rossi
E and Monfardini S: The development of platinum compounds and their
possible combination. Crit Rev Oncol Hematol. 60:59–75. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Voland C, Bord A, Peleraux A, Penarier G,
Carriere D, Galiegue S, Cvitkovic E, Jbilo O and Casellas P:
Repression of cell cycle-related proteins by oxaliplatin but not
cisplatin in human colon cancer cells. Mol Cancer Ther.
5:2149–2157. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Saralamma VV, Nagappan A, Hong GE, Lee HJ,
Yumnam S, Raha S, Heo JD, Lee SJ, Lee WS, Kim EH and Kim GS:
Poncirin induces apoptosis in AGS human gastric cancer cells
through extrinsic apoptotic pathway by up-regulation of Fas ligand.
Int J Mol Sci. 16:22676–22691. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kee JY, Han YH, Kim DS, Mun JG, Park J,
Jeong MY, Um JY and Hong SH: Inhibitory effect of quercetin on
colorectal lung metastasis through inducing apoptosis, and
suppression of metastatic ability. Phytomedicine. 23:1680–1690.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Garg H, Suri P, Gupta JC, Talwar GP and
Dubey S: Survivin: A unique target for tumor therapy. Cancer Cell
Int. 16:492016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Altieri DC: Survivin-the inconvenient IAP.
Semin Cell Dev Biol. 39:91–96. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang C, Wang W, Liu T, Wu Y, Guo H, Wang
P, Tian Q, Wang Y and Yuan Z: Doxorubicin-loaded glycyrrhetinic
acid-modified alginate nanoparticles for liver tumor chemotherapy.
Biomaterials. 33:2187–2196. 2012. View Article : Google Scholar : PubMed/NCBI
|
